Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

hu1124

Known as: Hu 1124 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
OBJECTIVE: To review the pharmacology, efficacy, and safety of efalizumab for the treatment of moderate to severe plaque… Expand
  • table 1
  • table 3
  • table 4
Is this relevant?
Review
2002
Review
2002
  • Drugs in R&D
  • 2002
  • Corpus ID: 13572617
 
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Anti-CD11a (hu1124) is a humanized monoclonal antibody directed against the CD11a subunit of LFA-1. This study… Expand
Is this relevant?
Review
2001
Review
2001
BIOLOGIC agents have been used in transplantation in the prophylaxis of rejection, in the induction phase of therapy, and in the… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND CD11a/CD18 comprise subunits of leukocyte function associated antigen (LFA-1), a T-cell surface molecule important in… Expand
Is this relevant?
2000
2000
  • Håkan Granlund
  • IDrugs : the investigational drugs journal
  • 2000
  • Corpus ID: 10234921
Genentech and XOMA are collaborating in the development of a humanized monoclonal antibody, hu1124 (anti-CD11a), which has the… Expand
Is this relevant?
2000
2000
  • 2000
  • Corpus ID: 195131707
 
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The pharmacokinetics of hu1124, a human anti-CD11a antibody, were investigated in human subjects with psoriasis. CD11a is a… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Is this relevant?